脑肿瘤治疗市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

脑肿瘤治疗市场按脑癌类型(胶质母细胞瘤、脑膜瘤、垂体瘤和其他类型的脑癌)、治疗和地理细分。

市场快照

Brain Tumor Therapeutics Market picture 1
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

脑肿瘤治疗市场预计将在预测期内实现 9.5% 的显着增长率。这种增长归因于脑肿瘤负担的增加、提高认识和增加对癌症治疗的研发。当大脑内形成异常细胞时,就会发生脑肿瘤。有两种主要类型的肿瘤,恶性或癌性肿瘤和良性肿瘤。

根据世界癌症研究基金 2018 年的统计,脑癌和中枢神经系统癌症占新发癌症病例总数的 1.7%,即 2018 年新发病例 296,851 例。预计全球脑癌负担的增加将推动脑部的需求预测期内的肿瘤治疗市场。 

脑肿瘤的治疗因几个因素而异,例如年龄、一般健康状况以及肿瘤的大小、位置和类型。

然而,癌症治疗的高成本和与脑肿瘤治疗相关的副作用预计将阻碍预测期内的市场增长。

报告范围

脑瘤是由大脑中癌细胞的异常生长引起的。在全球范围内,脑肿瘤是导致死亡的主要原因之一。脑膜瘤是最常见的脑肿瘤,也是最难治疗的一种,而神经胶质瘤的治疗通常有更好的结果。

Type of Brain Cancer
Glioblastoma
Meningioma
Pituitary Tumors
Other Types of Brain Cancer
Therapy
Chemotherapy
Immunotherapy
Gene Therapy
Other Therapies
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

免疫治疗领域有望实现强劲增长

  • 免疫疗法是通过激活或抑制免疫系统来治疗疾病。疫苗是一种很有前途的新型免疫疗法,可以刺激免疫系统对抗癌症。 
  • 已发现在多形性胶质母细胞瘤(成人最常见的原发性恶性脑肿瘤)中使用免疫疗法是有效的。 
  • AstraZeneca 的 AZD1390 是一种高效的脑渗透性 ATM(共济失调毛细血管扩张突变体)激酶抑制剂,可阻断 ATM 依赖性信号传导和基因组中 DNA 双链断裂 (DSB) 的修复。这是阿斯利康为治疗脑肿瘤而开发的用户。 
  • 因此,为开发治疗脑肿瘤的免疫疗法而不断增加的研发计划以及政府当局对开发机会疗法的持续支持预计将在预测期内推动该细分市场的增长。
brain.png

预计美国将在预测期内保持最大的市场份额

预计北美脑肿瘤市场在预测期内将占据重要份额。预计美国将引领市场,这归功于发达的医疗保健行业,以及该地区民众对先进技术的认识不断提高。

根据美国癌症协会的数据,2020 年将诊断出约 23,890 例脑或脊髓恶性肿瘤(男性 13,590 例,女性 10,300 例)。此外,同一份报告指出,约有 18,020 人(10,190 男性和 7,830 女性)将死于2020 年的脑和脊髓肿瘤。 

此外,脑膜瘤是最常见的脑肿瘤形式,其次是神经胶质瘤。依氟鸟氨酸在美国被指定为孤儿药,并获得了治疗间变性胶质瘤的突破性治疗指定。这可能会对预测期内市场的增长产生积极影响。

Brain Tumor Therapeutics Market - Growth Rate by Region - Image

竞争格局

脑肿瘤治疗市场高度集中,少数全球参与者控制着相当大的市场份额。市场上的主要参与者包括 Amgen Inc.、AstraZeneca PLC、Bayer AG、Bristol-Myers Squibb Co、F. Hoffmann-La Roche Ltd、GlaxoSmithKline PLC、Johnson & Johnson、Merck & Co. Inc.、Novartis AG 和 Pfizer Inc. .,等等。

主要玩家

  1. Bayer AG

  2. F. Hoffmann-La Roche Ltd

  3. Eisai Inc.

  4. Novartis AG

  5. Merck & Co. Inc.

Brain Tumor Therapeutics Market picture 4

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Incidence of Brain Tumor

      2. 4.2.2 Strong R&D Initiatives from Key Players

      3. 4.2.3 Increasing Government Initiatives for Cancer Awareness

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Cancer Therapies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type of Brain Cancer

      1. 5.1.1 Glioblastoma

      2. 5.1.2 Meningioma

      3. 5.1.3 Pituitary Tumors

      4. 5.1.4 Other Types of Brain Cancer

    2. 5.2 Therapy

      1. 5.2.1 Chemotherapy

      2. 5.2.2 Immunotherapy

      3. 5.2.3 Gene Therapy

      4. 5.2.4 Other Therapies

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Amgen Inc.

      2. 6.1.2 AstraZeneca PLC

      3. 6.1.3 Bayer AG

      4. 6.1.4 Bristol-Myers Squibb Co

      5. 6.1.5 Eisai Inc.

      6. 6.1.6 F. Hoffmann-La Roche Ltd

      7. 6.1.7 GlaxoSmithKline PLC

      8. 6.1.8 Johnson & Johnson

      9. 6.1.9 Merck & Co. Inc.

      10. 6.1.10 Novartis AG

      11. 6.1.11 Pfizer Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Brain Tumor Therapeutics Market market is studied from 2018 - 2026.

The Brain Tumor Therapeutics Market is growing at a CAGR of 9.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Bayer AG, F. Hoffmann-La Roche Ltd, Eisai Inc., Novartis AG, Merck & Co. Inc. are the major companies operating in Brain Tumor Therapeutics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!